Ginger as a nutraceutical shield: Counteracting acrylamide-induced liver injury

Abstract

Acrylamide, a contaminant formed during high-temperature cooking of common foods, is increasingly recognized as a silent and underestimated contributor to liver injury. In this editorial, we comment on the study by Nour El Deen et al, demonstrating that a chemically standardized ginger (Zingiber officinale) extract (≥ 20% 6-gingerol) mitigates acrylamide-induced hepatotoxicity in rats through antioxidant, anti-inflammatory, and cytoprotective mechanisms. By combining biochemical, histopathological, and molecular evidence, the authors establish a coherent experimental basis for future translational research. Their results are consistent with a growing body of data supporting the hepatoprotective properties of ginger and emphasize the importance of using standardized nutraceutical preparations in preventive hepatology. From a precision-nutrition perspective, ginger phytocompounds appear to influence key oxidative, inflammatory, and metabolic pathways, possibly involving the gut-liver axis. Confirmatory studies in chronic exposure models and human cohorts, together with compositional and protein-level validation, will be essential to strengthen both the mechanistic and translational significance of these findings.

Keywords: Ginger; Acrylamide exposure; Hepatotoxicity; Oxidative stress; Precision nutraceuticals

Core Tip: Acrylamide, a common food contaminant, contributes to liver injury through oxidative and inflammatory mechanisms. Nour El Deen et al demonstrate that a standardized ginger extract (≥ 20% 6-gingerol) protects against acrylamide-induced hepatotoxicity in rats. The editorial highlights the broader implications of such findings: Standardized nutraceuticals can serve as accessible tools for preventive hepatology. Within a precision-nutrition context, rigorous compositional and molecular validation will be essential to translate these preclinical observations into human relevance.